Total # cancer cases (2018)
Total # cancer deaths (2018)
7,664 3,916
26.9%
aPAF, cancer deaths bPAF, cancer cases cPAF, melanoma cases
TRENDS
Estimated past and future trends in total cases per year (breast and lung) Probability of premature death from cancer per year
INVESTMENT CASE (2019)
*High income
At this income level, investing in a package of essential services and scaling-up coverage will:
Costs per year Projected lives saved per year
Cancer Country Profile 2020
UV (2012)c Occupational risk (2017)a
79.8% 2.0%
1,325,649
Premature deaths from NCDs (2016)
Cancer as % of NCD premature deaths (2016)
7.7%
PAFs
(population attributable fractions)
3,842
Alcohol (2016)a Infections (2012)b Obesity (2012)b
8.8% 5.0%
ESTONIA
BURDEN OF CANCER
37.5%
Total population (2019)
Tobacco (2017)a
10.5%
3.6%
12.3%
3.2%
5.2%
11.1%
3.1%
3.7%
16.3%
4.3%
6.4%
2.6%
12.3%
1.5%
4.2%
18.4%
1.6%
6.7%
8.0%
7.0%
Breast Bladder Colorectum Corpus uteri Kidney Lung Melanoma of skin Pancreas Prostate Stomach
Most common cancer cases (2018)
Incidence Mortality
0 0 0 0 0 1 1 1 1 1 1
2020 2022 2024 2026 2028 2030
10.69%
10.46%10.25%9.91%10.08%10.01%10.17%10.10%
9.35%9.17%8.84%9.01%9.08%
8.44%
8.67%
8.32%8.18%8.04%7.90%7.77%7.63%7.49%7.35%7.22%7.08%6.94%6.80%
6.66%
8.08%7.88%7.69%7.49%7.29%7.10%6.90%6.71%6.51%6.31%6.12%5.92%
5.73%
2.00%
7.00%
12.00%
17.00%
2000 2005 2010 2015 2020 2025 2030
Past trends Projected linear trend SDG target
658 632
801 853
783
1,036
- 200 400 600 800 1,000 1,200
Breast cancer Lung cancer
2012 2018 2040
- 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 0.90 1.00
2020 2022 2024 2026 2028 2030
US$ (per capita)
HEALTH SYSTEM CAPACITY
aper 10,000 cancer patients
WORKFORCE
aper 10,000 cancer patients
Quality of mortality registration*** 2007-2016 High 2019 no
# of radiation oncologista 2019 18.3
2019 14.4
# of mammographsa 2020 19.6 # of surgeonsa 2014 246.6
# of CT scannersa 2020 30.0 # of radiologista 2019 200.9
# of MRI scannersa 2020 23.5 # of nuclear medicine physiciana 2019 10.4
# of PET or PET/CT scannersa 2020 3.9 # of medical & pathology lab scientistsa n/a n/a
Integrated NCD plan 2019 operational 2019 2.6
NCCP (including cancer types) 2019 n/a 2019 3 cancer(s)
MPOWER measures fully implemented and
achieved 2018
2
Pathology services 2019 generally availableCancer management guidelines 2019 yes 2019 generally available
Palliative care included in their operational,
integrated NCD plan 2019 no
2015-2017 887
Breast cancer screening program 2019 yes
*Defined daily doses for statistical purposes (S-DDD) per miliion inhabitants per day Breast cancer screening program: Starting
age, target population 2019
50
GLOBAL INITIATIVES
Elimination of Cervical Cancer Global Initiative for Childhood Cancer
HPV vaccination programme coverage 2018 44.4 2020 35
Cervical cancer screening 2019 yes Early detection programme/guidelines 2019 no
Screening programme type 2019 organised Defined referral system 2019 no
Screening programme method 2019 PAP smear
Screening participation rates 2019
Early detection programme/guidelines 2019 yes
Defined referral system 2019 yes
Annual cancer cases (0-14 years old) Palliative care availability:
community/home-based care 2019 generally available Available staff in Ministry of Health who
dedicates significant proportion of their time to cancer
# of medical physicista
Early detection programme/ guidelines for 4 cancers (breast, cervix, colon, childhood)
Cancer Country Profile 2020
High quality PBCR
2019 7.8
FORMULATING RESPONSE
# of external beam radiotherapy (photon,electron)a
ESTONIA
>50% and <70%
Annual cancer cases (0-14 years old) Bone marrow transplantation capacity
# Public cancer centres per 10,000 cancer patients
# of treatment services (surgery,
radiotherapy, chemotherapy) 2019 3 Availability of opioids* for pain
management Availability of population-based cancer
registry (PBCR)** 2019
8
2 1 4 2 1
17
Acute lymphoid leukaemia Hodgkin lymphoma Burkitt lymphoma CNS, low grade tumours Retinoblastoma Wilms tumour Other childhood cancer
